SOGC CLINICAL PRACTICE GUIDELINEActive Management of the Third Stage of Labour: Prevention and Treatment of Postpartum Hemorrhage
REFERENCES (55)
- et al.
Postpartum haemorrhage
Curr Obstet Gynaecol
(2006) - et al.
Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial
Am J Obstet Gynecol
(1997) - et al.
A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage
Am J Obstet Gynecol
(2001 Oct) A comparison of ‘active’ and ‘physiological’ management of the third stage of labour
Midwifery
(1990)- et al.
Hemodynamic effects of oxytocin given as IV bolus or infusion on women undergoing caesarean section
Br J Anaesth
(2007) - et al.
Signs of myocardial ischemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during caesarean section
Br J Anaesth
(2008) - et al.
Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section
Am J Obstet Gynecol
(1999) - et al.
Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery: a double-blind randomized trial
J Obstet Gynaecol Can
(2004) - et al.
Misoprostol for third stage of labour [letter]
Lancet
(1996) - et al.
Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage
Obstet Gynecol
(2002)
Misoprostol use during the third stage of labor
Int J Gynaecol Obstet
(2003)
WHO multicentre randomised trial of misoprostol in the management of the third stage of labour
Lancet
(2001)
Rectal misoprostol versus oxytocin in the management of the third stage of labour
J Obstet Gynaecol Can
(2007)
Distribution of blood between infant and placenta after birth
Lancet
(1969)
Third stage of labor: analysis of duration and clinical practice
Am J Obstet Gynecol
(1995)
Surgical management of severe obstetrical hemorrhage: experience with an obstetrical hemorrhage equipment tray
J Obstet Gynaecol Can
(2004)
Uterine artery embolization: an underused method of controlling pelvic hemorrhage
Am J Obstet Gynecol
(1997)
Hemostatic suturing technique for uterine bleeding during cesarean delivery
Obstet Gynecol
(2000)
Global burden of maternal death and disability
Br Med Bull
(2003)
Postpartum hemorrhage: practical approach to a life-threatening complication
Clin Exp Obstet Gynecol
(2006)
Postpartum hemorrhage: frequency, consequences in terms of health status, and risk factors before delivery
J Gynecol Obstet Biol Reprod (Paris)
(2004)
Maternal mortality in Giza, Egypt: magnitude, causes, and prevention
Stud Fam Plann
(1992)
Approach to the patient with shock
Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions
BJOG
(2006)
Active versus expectant management in the third stage of labour
Cochrane Database Syst Rev
(2000)
Joint statement: management of the third stage of labour to prevent post-partum haemorrhage
J Midwifery Womens Health
(2004)
Recommendations for the Prevention of Postpartum Haemorrhage
(2007)
Cited by (221)
Dose-dependent increase in risk of bleeding and bleeding complications in relation to SSRI use at delivery
2024, European Journal of Obstetrics and Gynecology and Reproductive BiologyThird stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes
2024, American Journal of Obstetrics and GynecologyTranexamic acid versus misoprostol for management of postpartum hemorrhage: A systematic review and meta-analysis of randomized controlled trials
2023, European Journal of Obstetrics and Gynecology and Reproductive BiologyTiming of umbilical cord occlusion, delayed vs early, in preterm babies: A randomized controlled trial (CODE-P Trial)
2023, European Journal of Obstetrics and Gynecology and Reproductive BiologyProphylactic tranexamic acid among women undergoing vaginal delivery to reduce postpartum blood loss and related morbidities: A systematic review and meta-analysis of 17 randomized controlled trials
2022, Journal of Gynecology Obstetrics and Human Reproduction
This Clinical Practice Guideline has been prepared by the Clinical Practice Obstetrics Committee and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.
Disclosure statements have been received from all members of the committee.
This document reflects emerging clinical and scientific advances on the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Local institutions can dictate amendments to these opinions. They should be well documented if modified at the local level. None of these contents may be reproduced in any form without prior written permission of the SOGC.
Copyright © 2009 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.